Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Gross Margin (2020 - 2025)

Historic Gross Margin for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 970.34%.

  • iSpecimen's Gross Margin fell 10119600.0% to 970.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.38%, marking a year-over-year decrease of 543500.0%. This contributed to the annual value of 42.93% for FY2024, which is 85200.0% down from last year.
  • Latest data reveals that iSpecimen reported Gross Margin of 970.34% as of Q3 2025, which was down 10119600.0% from 37.71% recorded in Q2 2025.
  • iSpecimen's 5-year Gross Margin high stood at 66.39% for Q3 2021, and its period low was 970.34% during Q3 2025.
  • For the 5-year period, iSpecimen's Gross Margin averaged around 5.84%, with its median value being 49.87% (2023).
  • As far as peak fluctuations go, iSpecimen's Gross Margin surged by 104200bps in 2024, and later crashed by -10119600bps in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Gross Margin stood at 52.05% in 2021, then rose by 1bps to 52.4% in 2022, then decreased by -15bps to 44.58% in 2023, then plummeted by -77bps to 10.26% in 2024, then plummeted by -9560bps to 970.34% in 2025.
  • Its Gross Margin was 970.34% in Q3 2025, compared to 37.71% in Q2 2025 and 37.85% in Q1 2025.